Estrogen-induced breast oncogenesis: modulation by an Aurora kinase inhibitor.
Li
Sara Antonia
SA
Department of Pharmacology, University of Kansas University Medical Center, Kansas City, KS, USA.
Lam
Luke K T
LK
Ahmed
Nayaz
N
Hontz
Adrianne E
AE
Li
Jonathan J
JJ
D000818:Animals; D064127:Aurora Kinases; D001943:Breast Neoplasms / Q000209:etiology*; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D004967:Estrogens / Q000009:adverse effects*; D006801:Humans; D010879:Piperazines / Q000494:pharmacology*; D017346:Protein Serine-Threonine Kinases / Q000037:antagonists & inhibitors*; D003521:Cyclopropanes; D011720:Pyrazoles; D011743:Pyrimidines
D064127:Aurora Kinases; D004791:Enzyme Inhibitors; D004967:Estrogens; D010879:Piperazines; D017346:Protein Serine-Threonine Kinases; C484810:tozasertib; D003521:Cyclopropanes; D011720:Pyrazoles; D011743:Pyrimidines